Cargando…

Immunotherapy Strategies for the Prevention and Treatment of Distinct Stages of Type 1 Diabetes: An Overview

Type 1 diabetes mellitus is a heterogeneous disorder characterized by destruction of pancreatic β cells, culminating in absolute insulin deficiency. The goals of Type 1 diabetes care, established by the Diabetes Control and Complications Trial (DCCT), are to achieve good glycemic control, to prevent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rapini, Novella, Schiaffini, Riccardo, Fierabracci, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139632/ https://www.ncbi.nlm.nih.gov/pubmed/32204344 http://dx.doi.org/10.3390/ijms21062103

Ejemplares similares

Increased incidence of childhood type 1 diabetes during the COVID‐19 pandemic. Figures from an Italian tertiary care center
por: Schiaffini, Riccardo, et al.
Publicado: (2022)

School and pre-school children with type 1 diabetes during Covid-19 quarantine: The synergic effect of parental care and technology
por: Schiaffini, Riccardo, et al.
Publicado: (2020)

Post-traumatic stress disorder (PTSD) in parents of children with type 1 diabetes during Covid-19 pandemic
por: Carducci, C., et al.
Publicado: (2021)

SARS-CoV-2 infection as possible downstream disease precipitator in autoantibody-positive insulin-dependent diabetes mellitus: a case report
por: Schiaffini, Riccardo, et al.
Publicado: (2022)

Functional and Taxonomic Traits of the Gut Microbiota in Type 1 Diabetes Children at the Onset: A Metaproteomic Study
por: Levi Mortera, Stefano, et al.
Publicado: (2022)

Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus
por: Perri, Valentina, et al.
Publicado: (2015)

Autoimmune Addison's Disease as Part of the Autoimmune Polyglandular Syndrome Type 1: Historical Overview and Current Evidence
por: Perniola, Roberto, et al.
Publicado: (2021)

Pathophysiology of Type 1 Diabetes and Gut Microbiota Role
por: Del Chierico, Federica, et al.
Publicado: (2022)

Monogenic diabetes clinic (MDC): 3-year experience
por: Rapini, Novella, et al.
Publicado: (2022)

Advances in Immunotherapeutic Approaches to Type 1 Diabetes
por: Cudini, Annamaria, et al.
Publicado: (2023)

Correction to: Monogenic diabetes clinic (MDC): 3‑year experience
por: Rapini, Novella, et al.
Publicado: (2022)

Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T PTPN22 Variant for Immunotherapy in Endocrine Autoimmunity
por: Arena, Andrea, et al.
Publicado: (2022)

Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome (APECED): A “Rare” Manifestation in a “Rare” Disease
por: Fierabracci, Alessandra
Publicado: (2016)

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
por: Coppieters, Ken, et al.
Publicado: (2018)

Diabetes and prediabetes in children with cystic fibrosis
por: Schiaffini, Riccardo, et al.
Publicado: (2023)

Type 1 Diabetes and Its Multi-Factorial Pathogenesis: The Putative Role of NK Cells
por: Marca, Valeria La, et al.
Publicado: (2018)

A nationwide survey of Italian pediatric diabetologists about COVID-19 vaccination in children and adolescents with type 1 diabetes
por: Scaramuzza, Andrea E., et al.
Publicado: (2022)

Type 1 Diabetes at-risk children highly recognize Mycobacterium avium subspecies paratuberculosis epitopes homologous to human Znt8 and Proinsulin
por: Niegowska, Magdalena, et al.
Publicado: (2016)

Identification and functional characterization of CD8(+) T regulatory cells in type 1 diabetes patients
por: Pellegrino, Marsha, et al.
Publicado: (2019)

Mycobacterium avium subsp. paratuberculosis in an Italian Cohort of Type 1 Diabetes Pediatric Patients
por: Manca Bitti, Maria Luisa, et al.
Publicado: (2012)

Immunotherapy in Advanced Gastric Cancer: An Overview of the Emerging Strategies
por: Magalhães, Helena, et al.
Publicado: (2018)

Immunotherapy in breast cancer: an overview of current strategies and perspectives
por: Debien, Véronique, et al.
Publicado: (2023)

Insights into the Role of MicroRNAs in the Onset and Development of Diabetic Neuropathy
por: Simeoli, Raffaele, et al.
Publicado: (2019)

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Human trials and a look into the future
por: Rewers, Marian, et al.
Publicado: (2009)

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
por: Bresson, Damien, et al.
Publicado: (2009)

Time With Glucose Level in Target Range Among Children and Adolescents With Type 1 Diabetes After a Software Update to a Closed-Loop Glucose Control System
por: Marigliano, Marco, et al.
Publicado: (2022)

Preparation and In Vitro Evaluation of RITUXfab-Decorated Lipoplexes to Improve Delivery of siRNA Targeting C1858T PTPN22 Variant in B Lymphocytes
por: Arena, Andrea, et al.
Publicado: (2021)

Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case report
por: Di Lorenzo, Biagio, et al.
Publicado: (2022)

An Overview on Probiotics as an Alternative Strategy for Prevention and Treatment of Human Diseases
por: Taherian, Mahdi, et al.
Publicado: (2019)

Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus
por: Huang, Mingshu, et al.
Publicado: (2023)

Strategies for the prevention of autoimmune Type 1 diabetes
por: Todd, J A, et al.
Publicado: (2011)

Detection of GAD65 Autoreactive T-Cells by HLA Class I Tetramers in Type 1 Diabetic Patients
por: Giuliani, Laura, et al.
Publicado: (2009)

Editorial: Diabetic ketoacidosis in children and adolescents: From epidemiological data to clinical aspects
por: Zucchini, Stefano, et al.
Publicado: (2023)

Gut Microbiota Functional Traits, Blood pH, and Anti-GAD Antibodies Concur in the Clinical Characterization of T1D at Onset
por: Del Chierico, Federica, et al.
Publicado: (2022)

Insights into the Diagnostic Potential of Extracellular Vesicles and Their miRNA Signature from Liquid Biopsy as Early Biomarkers of Diabetic Micro/Macrovascular Complications
por: La Marca, Valeria, et al.
Publicado: (2017)

Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type
por: Maccaroni, Elena, et al.
Publicado: (2021)

COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis
por: Fierabracci, Alessandra, et al.
Publicado: (2020)

Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments
por: Brandi, Giovanni, et al.
Publicado: (2019)

Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
por: Draghiciu, Oana, et al.
Publicado: (2015)

Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia
por: d'Annunzio, Giuseppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nfnmm9jumiip7l03s3hjid4u20